New Add-On treatment tested for Tough-to-Treat kidney cancer
NCT ID NCT05363631
Summary
This study is testing whether adding a supplement called Seleno-L Methionine (SLM) to two standard kidney cancer drugs (axitinib and pembrolizumab) is safe and more effective. It will involve about 55 adults with advanced kidney cancer that has spread or cannot be removed by surgery. The goal is to see if this three-part combination can better control the cancer without causing worse side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLEAR CELL RENAL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Iowa Hospitals & Clinics
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.